Trial record 1 of 3 for:    Aerovant AND asthma
Previous Study | Return to List | Next Study

A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL

This study has been completed.
Sponsor:
Information provided by:
Aerovance, Inc.
ClinicalTrials.gov Identifier:
NCT00801853
First received: December 1, 2008
Last updated: January 25, 2011
Last verified: November 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)